首页> 美国卫生研究院文献>SpringerPlus >Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae Chlamydiapneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens
【2h】

Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae Chlamydiapneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens

机译:开发一种用于从呼吸道临床标本中检测肺炎支原体肺炎衣原体肺炎和与肺炎支原体大环内酯耐药相关的突变的实时荧光定量PCR检测方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to improve detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in clinical specimens by developing a multiplex real-time PCR assay that includes identification of macrolide-resistant M. pneumoniae. Novel assays targeting a M. pneumoniae conserved hypothetical protein gene, M. pneumoniae 23S rRNA gene mutations associated with macrolide resistance and human β-globin gene (an endogenous internal control) were designed and combined with a previously published C. pneumoniae PCR targeting ompA gene. The resulting quadraplex PCR was validated with a panel of clinical specimens supplemented with external quality assessment specimens, simulated specimens and various bacterial and viral strains. The obtained results were compared to those obtained by reference PCRs or confirmed by sequencing (typing of macrolide resistance). The novel multiplex PCR assay was in 100 % agreement with reference PCRs. Four M. pneumoniae strains with macrolide resistance-associated mutations were identified among 42 strains, which comprises 9.5 % of the study material. Amplification of an internal control excluded sample-derived inhibition possibly leading to false-negative reporting. In conclusion, we have developed a resources conserving multiplex real-time PCR assay for simultaneous detection of M. pneumoniae, C. pneumoniae and the most common mutations leading to macrolide resistance in M. pneumoniae. The assay is a widely useful tool for detection of these respiratory pathogens and will also shed light on the occurrence of macrolide resistance in M. pneumoniae.Electronic supplementary materialThe online version of this article (doi:10.1186/s40064-015-1457-x) contains supplementary material, which is available to authorized users.
机译:这项研究的目的是通过开发一种多重实时荧光定量PCR检测方法来改善临床标本中肺炎支原体和肺炎衣原体的检测,其中包括鉴定对大环内酯类耐药的肺炎支原体。设计了针对肺炎支原体保守的假设蛋白基因,与大环内酯抗药性和人β-珠蛋白基因(内源性内部对照)相关的肺炎支原体23S rRNA基因突变的新型检测方法,并将其与先前发表的针对ompA基因的肺炎衣原体PCR结合使用。通过一组临床标本,外部质量评估标本,模拟标本以及各种细菌和病毒株,对得到的四链体PCR进行了验证。将获得的结果与通过参考PCR获得的结果进行比较,或通过测序(大环内酯类耐药性的分型)进行确认。新型多重PCR分析与参考PCR的一致性为100%。在42株菌株中鉴定出4种具有大环内酯抗药性相关突变的肺炎支原体菌株,占研究材料的9.5%。内部对照的扩增排除了样品衍生的抑制作用,可能导致假阴性报告。总之,我们已经开发了一种资源节约的多重实时PCR检测方法,用于同时检测肺炎支原体,肺炎衣原体和导致肺炎支原体耐药的最常见突变。该测定法是检测这些呼吸道病原体的广泛有用的工具,还将阐明肺炎支原体中大环内酯类药物的耐药性。电子补充材料本文的在线版本(doi:10.1186 / s40064-015-1457-x)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号